AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

WHWK · NASDAQ · Biotechnology

Whitehawk Therapeutics (WHWK)

Develops in-licensed antibody-drug conjugates for cancer treatment.

$3.82

After hours−0.02 (−0.39%)

At close$3.84(−5.07%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Insiders	2.89%	1.65M shares
5 holders · as of May 18, 2026
Strategic holders	8.29%	4.73M shares
1 holder · as of Mar 11, 2025
Other	88.82%	50.64M shares
remainder

57.01M company shares as of Aug 21, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

Holder	Stake	Shares	Date
Suvretta Capital Management, LLCStrategic	8.29%	4.73M	filed Mar 11, 2025
OrbiMed Advisors LLCInstitution	7.31%	4.17M	filed May 15, 2025
Coastlands Capital LPInstitution	4.95%	2.82M	filed Aug 25, 2025
David James LennonInsiderdirector, officer: CHIEF EXECUTIVE OFFICER	1.00%	569,643	filed May 18, 2026
Bryan BallInsiderofficer: See remarks	0.79%	448,126	filed May 18, 2026
Scott M. GiacobelloInsiderofficer: CHIEF FINANCIAL OFFICER	0.58%	333,489	filed May 18, 2026
Caley CasteleinInsiderdirector	0.48%	274,796	filed May 18, 2026
Margaret DuganInsiderofficer: Chief Medical Officer	0.03%	19,132	filed May 18, 2026
Anupam Dalal¹Insiderdirector	0.00%	0	filed Jul 30, 2026
QVT Financial LPInstitution	—9.37% of class, as filed	—	filed Feb 14, 2025

Anupam Dalal reports a block also reported by Suvretta Capital Management, LLC; it is counted once, under Suvretta Capital Management, LLC.

13F

No 13F holders on record.

13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Suvretta Capital Management, LLC	9.99%	4.73M	13G	Mar 11, 2025
QVT Financial LP	9.37%	2.31M	13G	Feb 14, 2025
OrbiMed Advisors LLC	8.90%	4.17M	13G	May 15, 2025
Coastlands Capital LP	5.98%	2.82M	13G	Aug 25, 2025

Form 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Apr 16, 2026	Scott M. Giacobelloofficer: CHIEF FINANCIAL OFFICER	Sale	141,600	$4.13	295,224
Apr 15, 2026	Scott M. Giacobelloofficer: CHIEF FINANCIAL OFFICER	Sale	77,000	$3.86	436,824
Apr 14, 2026	Bryan Ballofficer: See remarks	Sale	92,460	$3.64	397,106
Apr 13, 2026	Bryan Ballofficer: See remarks	Sale	26,389	$3.46	489,566
Apr 10, 2026	Bryan Ballofficer: See remarks	Sale	6,596	$3.43	515,955
Apr 9, 2026	Bryan Ballofficer: See remarks	Sale	50,000	$3.57	522,551
Apr 9, 2026	David James Lennondirector, officer: CHIEF EXECUTIVE OFFICER	Sale	14,500	$3.38	518,622
Apr 8, 2026	David James Lennondirector, officer: CHIEF EXECUTIVE OFFICER	Sale	63,945	$3.40	533,122
Apr 7, 2026	David James Lennondirector, officer: CHIEF EXECUTIVE OFFICER	Sale	94,087	$3.43	597,067
Apr 6, 2026	David James Lennondirector, officer: CHIEF EXECUTIVE OFFICER	Sale	102,395	$3.51	691,154

House and Senate disclosures

Not reported.

Breakdown

Top shareholders

Institutions

Ownership statements

Insider trades

Latest trades

Congress